Esta página foi traduzida automaticamente e a precisão da tradução não é garantida. Por favor, consulte o versão em inglês para um texto fonte.

Portfolio Diet for Dyslipidemia: A Hong Kong Pilot Study

11 de novembro de 2026 atualizado por: The Hong Kong Polytechnic University

Feasibility Study of a Health Education Programme to Improve Portfolio Diet Adherence for Hong Kong Adults With Dyslipidemia

Background:

Dyslipidemia (raised blood cholesterol) is a widespread public health concern in Hong Kong. While medications like statins are commonly used, many individuals hesitate to take them, making effective dietary strategies essential for reducing cardiovascular disease risk. The Portfolio Diet is a proven plant-based dietary pattern that can significantly lower cholesterol levels, but its feasibility has not yet been thoroughly explored or culturally adapted for a non-Western population like Hong Kong.

Purpose:

This feasibility study aims to evaluate whether a culturally tailored Portfolio Diet health education programme is practical, acceptable, and effective for Hong Kong adults with dyslipidemia. The findings will help researchers understand the practical challenges and motivators participants face when trying to change their diet, which will guide the design of a future larger-scale trial.

Methods:

A total of 12 Chinese adults aged 18 to 65 with borderline or high total cholesterol will participate in a 4-week health education programme. The programme begins with a group session explaining the core dietary principles, followed by 3 weekly individual dietary consultations with a research dietitian. The diet plan and sample 7-day menus are culturally adapted to include food items commonly consumed in Chinese culture.

Participants' diet adherence will be assessed using 3-day dietary records at the beginning and end of the study. Additionally, researchers will track feasibility data such as recruitment and retention rates, session attendance, and the completeness of the dietary records. Following the 4-week programme, participants will join focus group interviews to share their personal feedback, experiences, and suggestions for improving the programme for long-term use.

Visão geral do estudo

Status

Ainda não está recrutando

Descrição detalhada

Background and Rationale:

Dyslipidemia is a major public health challenge in Hong Kong, affecting over half of the adult population. While standard management relies on lifestyle advice and pharmacotherapy (e.g., statins), patient hesitancy toward medication remains a significant barrier. The Portfolio Diet-a dietary pattern combining four cholesterol-lowering components (viscous fibers, plant sterols, plant proteins, and nuts)-has demonstrated clinical efficacy in reducing serum low-density lipoprotein-cholesterol (LDL-C) by a mean of 28.6% in Western cohorts. However, its feasibility, acceptability, and efficacy signal have not been explored in non-Western populations whose local dietary habits differ significantly. This feasibility study is a necessary prerequisite to adapt the dietary components into Chinese culture and inform the design of a future full-scale randomized controlled trial (RCT).

Objectives:

  1. To evaluate the feasibility and process metrics (recruitment, retention, and session attendance rates) of a culturally adapted Portfolio Diet health education programme.
  2. To assess the acceptability and participant burden (completion and compliance rates of 3-day dietary records).
  3. To explore the preliminary efficacy signal of the programme in improving Portfolio Diet adherence among Hong Kong adults with dyslipidemia.
  4. To identify facilitators and barriers to dietary change through qualitative feedback to enhance the future intervention plan.

Study Design and Interventions:

This is an interventional feasibility study utilizing a single-group, pre-post test design combined with a qualitative component. Twelve eligible Chinese adults with dyslipidemia will undergo a 4-week health education programme:

  • Week 1 (Group Session): Introduction to the principles of the Portfolio Diet, its cholesterol-lowering mechanisms, and its relationship with cardiometabolic health.
  • Weeks 2-4 (Individual Consultations): Three weekly sessions of personalized dietary consultations conducted by a research dietitian. Participants will receive a culturally tailored 7-day menu adjusted to commonly consumed food groups in Chinese culture, targeting five dietary pillars: nuts/seeds (45 g/day), plant protein (50 g/day), viscous fiber (20 g/day), plant sterols (2 g/day), and monounsaturated fatty acid-rich plant fats (45 g/day).

Qualitative Component:

Post-intervention, all 12 participants will be divided into two focus groups (6 participants per group) for a 1-hour semi-structured interview conducted by a trained research assistant. The interviews will be audio-recorded and will systematically explore four domains: programme acceptability, dietary changes and practicality, perceived benefits, and suggestions for long-term implementation in Hong Kong.

Data Collection and Dietary Analysis:

Quantitative clinical and socio-demographic data will be collected at baseline and at week 4 (post-intervention). Dietary adherence will be assessed using 3-day dietary records (2 weekdays and 1 weekend day) completed at both time points. Nutrient and individual component intakes will be rigorously analyzed using Food Processor Nutrition Analysis and Fitness software (Version 8.0, ESHA Research), utilizing localized food composition tables from China and Hong Kong to ensure accuracy.

Tipo de estudo

Intervencional

Inscrição (Estimado)

12

Estágio

  • Não aplicável

Contactos e Locais

Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.

Contato de estudo

Locais de estudo

      • Hong Kong, China
        • Department of Food Science and Nutrition, The Hong Kong Polytechnic University
        • Contato:

Critérios de participação

Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.

Critérios de elegibilidade

Idades elegíveis para estudo

18 anos a 65 anos (Adulto, Adulto mais velho)

Aceita Voluntários Saudáveis

Não

Gêneros Elegíveis para o Estudo

Tudo

Descrição

Inclusion Criteria:

  • Aged 18-65 years.
  • Of Chinese ethnicity.
  • Diagnosed with borderline or high total cholesterol (TC ≥ 5.2 mmol/L).
  • Overweight or obese, defined as a Body Mass Index (BMI) ≥ 23 kg/m2.
  • Currently residing in Hong Kong with no travel plans for the following 12 weeks.
  • Able and willing to maintain a regular lifestyle and eating habits throughout the study period.
  • Capable of providing voluntary written informed consent.

Exclusion Criteria:

  • Known history of alcohol, cigarette, or drug abuse within the past 3 months.
  • Known liver and/or renal dysfunction.
  • Known history of severe medical conditions (e.g., cardiovascular disease, diabetes, inflammatory bowel disease, cancer, or psychiatric illness).
  • Participation in any other interventional clinical trials within the past 3 months.

Plano de estudo

Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.

Como o estudo é projetado?

Detalhes do projeto

  • Finalidade Principal: Prevenção
  • Alocação: N / D
  • Modelo Intervencional: Atribuição de grupo único
  • Mascaramento: Nenhum (rótulo aberto)

Armas e Intervenções

Grupo de Participantes / Braço
Intervenção / Tratamento
Experimental: Portfolio Diet Education Group

A single group of 12 Hong Kong Chinese adults with dyslipidemia who receive a culturally adapted 4-week Portfolio Diet health education programme, followed by qualitative focus group interviews.

The programme consists of 4 weekly sessions. Week 1 is a group-based session introducing the principles of the Portfolio Diet and its clinical relationship with cardiometabolic health. Weeks 2 to 4 consist of 3 individual dietary consultations conducted by a research dietitian. The dietary components (nuts/seeds, plant protein, viscous fiber, plant sterols, and plant-based fats) are culturally adapted to commonly consumed food groups in Chinese culture. Participants receive a localized 7-day menu to help modify their diet.

O que o estudo está medindo?

Medidas de resultados primários

Medida de resultado
Descrição da medida
Prazo
Programme Retention Rate
Prazo: At the end of the 4-week intervention

The percentage of enrolled participants who successfully complete the entire 4-week health education programme. This metric is used to evaluate the feasibility of the study protocol and participant retention.

At the end of the 4-week intervention
Change in Portfolio Diet Adherence Score
Prazo: Baseline and Post-intervention (Week 4)

Assessed by 3-day dietary records (covering 2 weekdays and 1 weekend day) to evaluate the change in participant adherence to the Portfolio Diet pillars. Nutrient and dietary component intakes will be analyzed using Food Processor Nutrition Analysis and Fitness software (Version 8.0) with localized food composition tables.

Baseline and Post-intervention (Week 4)

Medidas de resultados secundários

Medida de resultado
Descrição da medida
Prazo
Participant Acceptability and Perceived Barriers via Focus Groups
Prazo: Post-intervention (Week 4)

Evaluated through post-intervention qualitative focus group interviews (6 participants per group). A semi-structured interview guide will be used to explore four core domains: acceptability of the programme format/duration, dietary changes and practical challenges, perceived health benefits, and suggestions for long-term implementation.

Post-intervention (Week 4)

Colaboradores e Investigadores

É aqui que você encontrará pessoas e organizações envolvidas com este estudo.

Datas de registro do estudo

Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados ​​pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.

Datas Principais do Estudo

Início do estudo (Estimado)

1 de janeiro de 2027

Conclusão Primária (Estimado)

31 de dezembro de 2027

Conclusão do estudo (Estimado)

31 de dezembro de 2027

Datas de inscrição no estudo

Enviado pela primeira vez

11 de novembro de 2026

Enviado pela primeira vez que atendeu aos critérios de CQ

11 de novembro de 2026

Primeira postagem (Real)

18 de novembro de 2026

Atualizações de registro de estudo

Última Atualização Postada (Real)

18 de novembro de 2026

Última atualização enviada que atendeu aos critérios de controle de qualidade

11 de novembro de 2026

Última verificação

1 de novembro de 2026

Mais Informações

Termos relacionados a este estudo

Plano para dados de participantes individuais (IPD)

Planeja compartilhar dados de participantes individuais (IPD)?

NÃO

Descrição do plano IPD

As this is a small-scale pilot feasibility study (N=12) focused on evaluating protocol processes and cultural acceptability, individual participant data will not be made publicly available to protect participant privacy.

Informações sobre medicamentos e dispositivos, documentos de estudo

Estuda um medicamento regulamentado pela FDA dos EUA

Não

Estuda um produto de dispositivo regulamentado pela FDA dos EUA

Não

Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .

Se inscrever